Thyroid Dysfunction and Alzheimer's Disease, a Vicious Circle

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2024 Feb 29

PMID 38419953

Authors

Zhaoqing Li

Jia Liu

Affiliations

Soon will be listed here.

Abstract

Recently, research into the link between thyroid dysfunction and Alzheimer's disease (AD) remains a current topic of interest. Previous research has primarily concentrated on examining the impact of thyroid dysfunction on the risk of developing AD, or solely explored the mechanisms of interaction between hypothyroidism and AD, a comprehensive analysis of the mechanisms linking thyroid dysfunction, including hyperthyroidism and hypothyroidism, to Alzheimer's disease (AD) still require further elucidation. Therefore, the aim of this review is to offer a thorough and comprehensive explanation of the potential mechanisms underlying the causal relationship between thyroid dysfunction and AD, highlighting the existence of a vicious circle. The effect of thyroid dysfunction on AD includes neuron death, impaired synaptic plasticity and memory, misfolded protein deposition, oxidative stress, and diffuse and global neurochemical disturbances. Conversely, AD can also contribute to thyroid dysfunction by affecting the stress repair response and disrupting pathways involved in thyroid hormone (TH) production, transport, and activation. Furthermore, this review briefly discusses the role and significance of utilizing the thyroid as a therapeutic target for cognitive recovery in AD. By exploring potential mechanisms and therapeutic avenues, this research contributes to our understanding and management of this devastating neurodegenerative disease.

Citing Articles

Transcriptome analysis of early- and late-onset Alzheimer's disease in Korean cohorts.

Han S, Hwang J, Park T, Pyun J, Lee J, Park J Alzheimers Dement. 2025; 21(2):e14563.

PMID: 39935412 PMC: 11815242. DOI: 10.1002/alz.14563.

Artificial Intelligence-Assisted Comparative Analysis of the Overlapping Molecular Pathophysiology of Alzheimer's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.

Wei Z, Iyer M, Zhao B, Deng J, Mitchell C Int J Mol Sci. 2025; 25(24.

PMID: 39769215 PMC: 11678588. DOI: 10.3390/ijms252413450.

Hyperthyroidism, hypothyroidism, thyroid stimulating hormone, and dementia risk: results from the NHANES 2011-2012 and Mendelian randomization analysis.

Sheng X, Gao J, Chen K, Zhu X, Wang Y Front Aging Neurosci. 2024; 16:1456525.

PMID: 39507203 PMC: 11538144. DOI: 10.3389/fnagi.2024.1456525.

Thyroid Function and Cognitive Decline: A Narrative Review.

Sinha S, Zietlow K, Papaleontiou M Endocr Pract. 2024; 30(11):1113-1118.

PMID: 39111592 PMC: 11800104. DOI: 10.1016/j.eprac.2024.07.013.

References

Camandola S, Mattson M . Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease. Biochim Biophys Acta. 2010; 1813(5):965-73. PMC: 3032815. DOI: 10.1016/j.bbamcr.2010.10.005. View

Krausz Y, Freedman N, Lester H, Newman J, Barkai G, Bocher M . Regional cerebral blood flow in patients with mild hypothyroidism. J Nucl Med. 2004; 45(10):1712-5. View

Tang X, Song Z, Wang D, Yang J, Cardoso M, Zhou J . Spectrum of thyroid dysfunction and dementia: a dose-response meta-analysis of 344,248 individuals from cohort studies. Endocr Connect. 2021; 10(4):410-421. PMC: 8111311. DOI: 10.1530/EC-21-0047. View

Bhat A, Dar K, Anees S, Zargar M, Masood A, Sofi M . Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother. 2015; 74:101-10. DOI: 10.1016/j.biopha.2015.07.025. View

Sanchez-Huerta K, Montes S, Perez-Severiano F, Alva-Sanchez C, Rios C, Pacheco-Rosado J . Hypothyroidism reduces glutamate-synaptic release by ouabain depolarization in rat CA3-hippocampal region. J Neurosci Res. 2011; 90(4):905-12. DOI: 10.1002/jnr.22806. View

Patel A, Hayashi M, Hunt A . Selective persistent reduction in choline acetyltransferase activity in basal forebrain of the rat after thyroid deficiency during early life. Brain Res. 1987; 422(1):182-5. DOI: 10.1016/0006-8993(87)90556-7. View

Zhang W, Liu X, Zhang Y, Song L, Hou J, Chen B . Disrupted functional connectivity of the hippocampus in patients with hyperthyroidism: evidence from resting-state fMRI. Eur J Radiol. 2014; 83(10):1907-13. DOI: 10.1016/j.ejrad.2014.07.003. View

Folkestad L, Brandt F, Lillevang-Johansen M, Brix T, Hegedus L . Graves' Disease and Toxic Nodular Goiter, Aggravated by Duration of Hyperthyroidism, Are Associated with Alzheimer's and Vascular Dementia: A Registry-Based Long-Term Follow-Up of Two Large Cohorts. Thyroid. 2020; 30(5):672-680. DOI: 10.1089/thy.2019.0672. View

Larsen C, Riis K, Winther K, Larsen E, Ellervik C, Hegedus L . Treatment of Hyperthyroidism Reduces Systemic Oxidative Stress, as Measured by Markers of RNA and DNA Damage. J Clin Endocrinol Metab. 2021; 106(7):e2512-e2520. DOI: 10.1210/clinem/dgab273. View

10.

Subhadra B, Schaller K, Seeds N . Neuroserpin up-regulation in the Alzheimer's disease brain is associated with elevated thyroid hormone receptor-β1 and HuD expression. Neurochem Int. 2013; 63(5):476-81. PMC: 3902180. DOI: 10.1016/j.neuint.2013.08.010. View

11.

Tobore T . On the Etiopathogenesis and Pathophysiology of Alzheimer's Disease: A Comprehensive Theoretical Review. J Alzheimers Dis. 2019; 68(2):417-437. DOI: 10.3233/JAD-181052. View

12.

Yeap B, Alfonso H, Chubb S, Puri G, Hankey G, Flicker L . Higher free thyroxine levels predict increased incidence of dementia in older men: the Health in Men Study. J Clin Endocrinol Metab. 2012; 97(12):E2230-7. DOI: 10.1210/jc.2012-2108. View

13.

de Jong F, Masaki K, Chen H, Remaley A, Breteler M, Petrovitch H . Thyroid function, the risk of dementia and neuropathologic changes: the Honolulu-Asia aging study. Neurobiol Aging. 2007; 30(4):600-6. PMC: 3147246. DOI: 10.1016/j.neurobiolaging.2007.07.019. View

14.

Fernandez M, Pirondi S, Manservigi M, Giardino L, Calza L . Thyroid hormone participates in the regulation of neural stem cells and oligodendrocyte precursor cells in the central nervous system of adult rat. Eur J Neurosci. 2004; 20(8):2059-70. DOI: 10.1111/j.1460-9568.2004.03664.x. View

15.

Rao G, Verma R, Mukherjee A, Haldar C, Agrawal N . Melatonin alleviates hyperthyroidism induced oxidative stress and neuronal cell death in hippocampus of aged female golden hamster, Mesocricetus auratus. Exp Gerontol. 2016; 82:125-30. DOI: 10.1016/j.exger.2016.06.014. View

16.

Mary A, Eysert F, Checler F, Chami M . Mitophagy in Alzheimer's disease: Molecular defects and therapeutic approaches. Mol Psychiatry. 2022; 28(1):202-216. DOI: 10.1038/s41380-022-01631-6. View

17.

Palm R, Ayala-Fontanez N, Garcia Y, Lee H, Smith M, Casadesus G . Neuroendocrinology-based therapy for Alzheimer's disease. Biofactors. 2012; 38(2):123-32. DOI: 10.1002/biof.1011. View

18.

Kumar M, Singh S, Rana P, Modi S, Sekhri T, Kanwar R . Brain functional connectivity in patients with hyperthyroidism after anti-thyroid treatment. J Neuroendocrinol. 2021; 34(1):e13075. DOI: 10.1111/jne.13075. View

19.

Zhou L, Ding S, Li Y, Wang L, Chen W, Bo T . Endoplasmic Reticulum Stress May Play a Pivotal Role in Lipid Metabolic Disorders in a Novel Mouse Model of Subclinical Hypothyroidism. Sci Rep. 2016; 6:31381. PMC: 4990971. DOI: 10.1038/srep31381. View

20.

de Jong F, den Heijer T, Visser T, de Rijke Y, Drexhage H, Hofman A . Thyroid hormones, dementia, and atrophy of the medial temporal lobe. J Clin Endocrinol Metab. 2006; 91(7):2569-73. DOI: 10.1210/jc.2006-0449. View